Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB00108"

Predicate	Value (sorted: default)
rdfs:label	"Natalizumab"
rdf:type	drugbank:drugs
drugbank:description	"Humanized IgG4k monoclonal antibody produced in murine myeloma cells. Natalizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to a4-integrin. Natalizumab was voluntarily withdrawn from U.S. market because of risk of Progressive multifocal leukoencephalopathy (PML). It was returned to market July, 2006."
drugbank:drugCategory	drugcategory:Immunosuppressive Agents
drugbank:interactsWith	drug:Trastuzumab drug:Tositumomab drug:Cladribine drug:Carmustine drug:Bleomycin drug:Chlorambucil drug:Tioguanine drug:Vinorelbine drug:Valrubicin drug:Teniposide drug:Cisplatin drug:Vincristine drug:Vinblastine drug:Clofarabine drug:Tretinoin drug:Temozolomide drug:Tacrolimus drug:Carboplatin drug:Topotecan drug:Thalidomide drug:Paclitaxel drug:Thiotepa drug:Homoharringtonine drug:ado-trastuzumab emtansine drug:Canakinumab drug:Temsirolimus drug:golimumab drug:Brentuximab vedotin drug:Teriflunomide drug:Tofacitinib drug:Certolizumab pegol
owl:sameAs	drug:BIOD00083 drug:BTD00083 drug:Trastuzumab drug:Tositumomab drug:Cladribine drug:Carmustine drug:Bleomycin drug:Chlorambucil drug:Tioguanine drug:Vinorelbine drug:Valrubicin drug:Teniposide drug:Cisplatin drug:Vincristine drug:Vinblastine drug:Clofarabine drug:Tretinoin drug:Temozolomide drug:Tacrolimus drug:Carboplatin drug:Topotecan drug:Thalidomide drug:Paclitaxel drug:Thiotepa drug:Homoharringtonine drug:ado-trastuzumab emtansine drug:Canakinumab drug:Temsirolimus drug:golimumab drug:Brentuximab vedotin drug:Teriflunomide drug:Tofacitinib drug:Certolizumab pegol

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines2/drugbank_small.nt

The resource appears as object in 62 triples

Context graph